Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Academic Article 2019 uri icon

authors

  • Cahn P
  • Sievers J
  • Man C
  • Currie A
  • Underwood M
  • Tenorio AR
  • Pappa K
  • Wynne B
  • Fettiplace A
  • Gartland M
  • Aboud M
  • Madero JS
  • Smith K
  • GEMINI Study Team
  • Arribas JR
  • Antinori A
  • MASIA CANUTO, MARIA DEL MAR
  • Ortiz R
  • PORTILLA SOGORB, JOAQUIN
  • Clarke AE
  • Hung CC
  • Rockstroh JK
  • Girard PM

publication date

  • 2019

published in